Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dyer

Showing results (61-70 of 1,103) with videos related to

Pageof 111
Sort By:
Journal of Clinical Pathology|May 29, 2004
Mouse models of childhood cancer of the nervous systemM A Dyer
JAMA Dermatology|May 30, 2013
Practice gaps. Propranolol to treat hemangiomas of infancy: safety and side effect recognitionJonathan A Dyer
Expert Opinion on Drug Safety|April 30, 2013
Safety and tolerability of paricalcitol in patients with chronic kidney diseaseChristopher A Dyer
Missouri Medicine|January 1, 1991
AMA policy: you can shape itG A Dyer
M.D. Computing : Computers in Medical Practice|February 5, 2000
MEDNET '99. Cybermedicine enters the new millenniumK A Dyer
The NAHAM Management Journal|July 1, 1999
Marketing in a managed care environmentD A Dyer
American Journal of Ophthalmology|February 1, 1975
New extraocular muscle clampJ A Dyer
Neurochemical Research|January 7, 2003
The structure and function of myelin: from inert membrane to perfusion pumpCharissa A Dyer
The American Journal of Medicine|September 1, 1995
. . . they just fade awayK A Dyer
Australian Journal of Ophthalmology|November 1, 1980
The artificial eyeN A Dyer
Pageof 111

Showing results (61-70 of 1,103) with videos related to

Sort By:
Pageof 111
Journal of Clinical Pathology|May 29, 2004
Mouse models of childhood cancer of the nervous systemM A Dyer
JAMA Dermatology|May 30, 2013
Practice gaps. Propranolol to treat hemangiomas of infancy: safety and side effect recognitionJonathan A Dyer
Expert Opinion on Drug Safety|April 30, 2013
Safety and tolerability of paricalcitol in patients with chronic kidney diseaseChristopher A Dyer
Missouri Medicine|January 1, 1991
AMA policy: you can shape itG A Dyer
M.D. Computing : Computers in Medical Practice|February 5, 2000
MEDNET '99. Cybermedicine enters the new millenniumK A Dyer
The NAHAM Management Journal|July 1, 1999
Marketing in a managed care environmentD A Dyer
American Journal of Ophthalmology|February 1, 1975
New extraocular muscle clampJ A Dyer
Neurochemical Research|January 7, 2003
The structure and function of myelin: from inert membrane to perfusion pumpCharissa A Dyer
The American Journal of Medicine|September 1, 1995
. . . they just fade awayK A Dyer
Australian Journal of Ophthalmology|November 1, 1980
The artificial eyeN A Dyer
Pageof 111